The Effect of Esketamine on Patients Undergoing Tumor Surgery
Status:
Active, not recruiting
Trial end date:
2021-10-15
Target enrollment:
Participant gender:
Summary
Although the acute and chronic postoperative pain of surgical patients has gradually been
paid attention to, it has not yet been better resolved.and, the incidence of anxiety and
depression in cancer patients is constantly increasing，The new analgesic anesthetic
esketamine hydrochloride was launched in China last year，however, in the domestic and foreign
literature, there are still few reports of esketamine hydrochloride in postoperative
analgesia, and most of them are retrospective and small samples.This study aims to
investigate whether esketamine has advantages over traditional opioids in terms of
postoperative analgesia, anxiety and depression in cancer patients.
Phase:
N/A
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University